| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |